Brief Strengths-Based Case Management Promotes Entry Into HIV Medical Care: Results of the Antiretroviral Treatment Access Study-II

Craw, Jason A MPH*†; Gardner, Lytt I PhD*; Marks, Gary PhD*; Rapp, Richard C MSW‡; Bosshart, Jeff MSW, MPH*; Duffus, Wayne A MD, PhD§∥; Rossman, Amber LMSW¶; Coughlin, Susan L MPH#; Gruber, DeAnn PhD**; Safford, Lauretta A MSW††; Overton, Jon MSW‡‡; Schmitt, Karla PhD, ARNP, MPH§§

JAIDS Journal of Acquired Immune Deficiency Syndromes: 15 April 2008 - Volume 47 - Issue 5 - pp 597-606
doi: 10.1097/QAI.0b013e3181684c51
Epidemiology and Social Science

Objective: The Antiretroviral Treatment Access Study-II (ARTAS-II) evaluated a brief case management intervention delivered in health departments and community-based organizations (CBOs) to link recently diagnosed HIV-infected persons to medical care rapidly.

Methods: Recently diagnosed HIV-infected persons were recruited from 10 study sites across the United States during 2005 to 2006. The intervention consisted of up to 5 sessions with an ARTAS linkage case manager over a 90-day period. The outcome measure was whether or not the participant had seen an HIV medical care provider at least once within 6 months of enrollment. Multivariate logistic regression was used to identify significant predictors of receiving HIV medical care.

Results: Seventy-nine percent (497 of 626) of participants visited an HIV clinician at least once within the first 6 months. Participants who were older than 25 years of age, Hispanic, and stably housed; had not recently used noninjection drugs; had attended 2 or more sessions with the case manager; and were recruited at a study site that had HIV medical care colocated on its premises were all significantly more likely to have received HIV care.

Conclusions: The ARTAS linkage case management intervention provides a model that health departments and CBOs can use to ensure that recently diagnosed HIV-infected persons attend an initial HIV care encounter.

From the *Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA; †Northrop Grumman Information Technology (CDC contractor), Atlanta, GA; ‡Center for Interventions, Treatment, and Addictions Research, Wright State University Boonshoft School of Medicine, Dayton, OH; §South Carolina Department of Health and Environmental Control, Columbia, SC; ∥University of South Carolina School of Medicine, Columbia, SC; ¶Kansas City Free Health Clinic, Kansas City, MO; #Institute for Health, Policy, and Evaluation Research, Duval County Health Department, Jacksonville, FL; **Louisiana Office of Public Health, HIV/AIDS Program, New Orleans, LA; ††Community Health Research Initiative, Virginia Commonwealth University, Richmond, VA; ‡‡Alliance for Community Empowerment, Chicago, IL; and the §§Bureau of Sexually Transmitted Disease Prevention and Control, Florida Department of Health, Tallahassee, FL.

Received for publication October 16, 2007; accepted January 11, 2008.

The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the Centers for Disease Control and Prevention.

Correspondence to: Jason A. Craw, MPH, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop E-45, Atlanta, GA 30333 (e-mail: emf4@cdc.gov).

Reprints to: Lytt I. Gardner, PhD, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop E-45, Atlanta, GA 30333 (e-mail: LGardner@cdc.gov).

© 2008 Lippincott Williams & Wilkins, Inc.